Anemia and quality of life including anemia-related symptoms in patients with solid tumors in clinical practice

Medical Oncology

Volumn 24, Issue 1, 2007, Pages 95-102

  Bremberg, E Rämme ^a,c   Brandberg, Y ^a,b   Hising, C ^a   Friesland, S ^a   Eksborg, S ^a,b  

^a KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

^b KAROLINSKA INSTITUTE   (Sweden)

^c PFIZER INC   (United States)

Author keywords

Cancer; Erythrocyte transfusion; Erythropoietin; Exercise; Fatigue; Hemoglobin; Neoplasm

Indexed keywords

ANTINEOPLASTIC AGENT; HEMOGLOBIN;

ADULT; AGED; ANEMIA; ARTICLE; BREAST CANCER; CANCER CHEMOTHERAPY; CANCER RADIOTHERAPY; CLINICAL PRACTICE; CONTROLLED STUDY; DIGESTIVE SYSTEM CANCER; ESOPHAGUS CANCER; FATIGUE; FEMALE; FUNCTIONAL ASSESSMENT OF CANCER THERAPY ANEMIA TRIAL OUTCOME INDEX; GYNECOLOGIC CANCER; HEAD AND NECK CANCER; HEMOGLOBIN BLOOD LEVEL; HUMAN; LUNG CANCER; MAJOR CLINICAL STUDY; MALE; MELANOMA; NAMED INVENTORIES, QUESTIONNAIRES AND RATING SCALES; PRIORITY JOURNAL; QUALITY OF LIFE; QUESTIONNAIRE; SOLID TUMOR; UNIVERSITY HOSPITAL; UROGENITAL TRACT CANCER; MIDDLE AGED; NEOPLASM; PROSPECTIVE STUDY;

ADULT; AGED; AGED, 80 AND OVER; ANEMIA; FATIGUE; FEMALE; HEMOGLOBINS; HUMANS; MALE; MIDDLE AGED; NEOPLASMS; PROSPECTIVE STUDIES; QUALITY OF LIFE; QUESTIONNAIRES;

EID: 34548764285     PISSN: 13570560     EISSN: None     Source Type: Journal    
DOI: 10.1007/BF02685909     Document Type: Article

References (25)

1. DP Lawrance B Kupelnick K Miller D Devine J Lau 2004 Evidence report on the occurrence, assessment, and treatment of fatigue in cancer patients J Natl Cancer Inst Monogr 32 40 50
2. B Woo SL Dibble BF Piper SB Keating MC Weiss 1998 Differences in fatigue by treatment methods in women with breast cancer Oncol Nurs Forum 25 915 920
3. NJ Vogelzang 1997 Patient, caregiver, and oncologist perceptions of cancer-related fatigue: results of a tripart assessment survey. The Fatigue Coalition Semin Hematol 34 4 12
4. P Stone 2000 Cancer-related fatigue: inevitable, unimportant and untreatable? Results of a multi-centre patient survey. Cancer Fatigue Forum Ann Oncol 11 971 975
5. A Osterborg Y Brandberg 2003 Relationship between changes in hemoglobin level and quality of life during chemotherapy in anemic cancer patients receiving epoetin alfa therapy Cancer 97 3125 3126
6. L Fallowfield 2002 Multivariate regression analyses of data from a randomised, double-blind, placebo-controlled study confirm quality of life benefit of epoetin alfa in patients receiving non-platinum chemotherapy Br J Cancer 87 1341 1353
7. M Hedenus 2003 Efficacy and safety of darbepoetin alfa in anaemic patients with lymphoproliferative malignancies: a randomized, double-blind, placebo-controlled study Br J Haematol 122 394 403
8. A Osterborg 2002 Randomized, double-blind, placebo-controlled trial of recombinant human erythropoietin, epoetin beta, in hematologic malignancies J Clin Oncol 20 2486 2494
9. TJ Littlewood E Bajetta JWR Nortier E Vercammen B Rapoport 2001 Effects of epoetin alfa on hematologic parameters and quality of life in cancer patients receiving nonplatinum chemotherapy: results of a randomized, double-blind, placebo-controlled trial J Clin Oncol 19 2865 2874
10. JE Johansson P Wersall Y Brandberg SO Andersson L Nordstrom 2001 Efficacy of epoetin beta on hemoglobin, quality of life, and transfusion needs in patients with anemia due to hormone-refractory prostate cancer-a randomized study Scand J Urol Nephrol 35 288 294
11. AM Olsson 2002 Erythropoietin treatment in metastatic breast cancer-effects on Hb, quality of life and need for transfusion Acta Oncol 41 517 524
12. B Glimelius 1998 Epoetin beta in the treatment of anemia in patients with advanced gastrointestinal cancer J Clin Oncol 16 434 440
13. J Vansteenkiste 2002 Double-blind, placebo-controlled, randomized phase III trial of darbepoetin alfa in lung cancer patients receiving chemotherapy J Natl Cancer Inst 94 1211 1220
14. M Boogaerts B Coiffier C Kainz 2003 Impact of epoetin beta on quality of life in patients with malignant disease Br J Cancer 88 988 995
15. J Chang F Couture S Young KL Mcwatters CY Lau 2005 Weekly epoetin alfa maintains hemoglobin, improves quality of life, and reduces transfusion in breast cancer patients receiving chemotherapy J Clin Oncol 23 2597 2605
16. D Cella 1997 The Functional Assessment of Cancer Therapy-Anemia (FACT-An) Scale: a new tool for the assessment of outcomes in cancer anemia and fatigue Semin Hematol 34 13 19
17. SB Yellen DF Cella K Webster C Blendowski E Kaplan 1997 Measuring fatigue and other anemia-related symptoms with the Functional Assessment of Cancer Therapy (FACT) measurement system J Pain Symptom Manag 13 63 74
18. Y Brandberg 2000 Assessing the impact of cancer-related anaemia on quality of life and the role of rHuEPO Med Oncol 17 Suppl 1 S23 31
19. B Holzner 2002 The impact of hemoglobin levels on fatigue and quality of life in cancer patients Ann Oncol 13 965 973
20. P Stone M Richards R A'Hern J Hardy 2000 A study to investigate the prevalence, severity and correlates of fatigue among patients with cancer in comparison with a control group of volunteers without cancer Ann Oncol 11 561 567
21. D Nordenberg R Yip NJ Binkin 1990 The effect of cigarette smoking on hemoglobin levels and anemia screening JAMA 264 1556 1559
22. P Kosmidis M Krzakowski The ECAS Investigators 2005 Anemia profiles in patients with lung cancer: what have we learned from the European Cancer Anaemia Survey (ECAS)? Lung Cancer 50 401 412
23. TN Munch T Zhang J Willey JL Palmer E Bruera 2005 The association between anemia and fatigue in patients with advanced cancer receiving palliative care J Palliat Med 8 1144 1149
24. V Mock 2001 Fatigue and quality of life outcomes of exercise during cancer treatment Cancer Pract 9 119 127
25. FC Dimeo 1997 Aerobic exercise in the rehabilitation of cancer patients after high dose chemotherapy and autologous peripheral stem cell transplantation Cancer 79 1717 1722